Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Pieris Stock Moves Higher On €14.2M Grant For PRS-220 In Post-COVID Pulmonary Fibrosis
Pieris Pharmaceuticals Inc (NASDAQ:PIRS) has announced the development of PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor…
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 24)
Pieris Pharma Reports Development Of PRS-220 For Idiopathic Pulmonary Fibrosis; $17M Grant From Bavarian Gov’t. To Accelerate Program Development For Post-COVID-19 Pulmonary Fibrosis
PRS-220, an oral inhaled Anticalin protein targeting CTGF, a fully proprietary drug candidate for respiratory disease, is being developed as a local treatment for idiopathic pulmonary fibrosis
Grant to enable the
45 Biggest Movers From Yesterday
Gainers
Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
36 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.